Mark Jackson

Dr. J. Mark Jackson joins Evommune from his position as a Clinical Professor of Medicine at the University of Louisville. Besides his academic appointment, he also previously served as an advisor to multiple pharmaceutical companies including AbbVie, Amgen, Arcutis, Bristol Myers Squibb, Dermavant, Galderma, Janssen, Eli Lilly, Novartis, Pfizer, an... d UCB, and held a leadership role in a clinical practice with Forefront Dermatology. He has been involved in clinical research for over 25 years, with a focus on early drug development. Mark has authored over 50 articles in peer reviewed publications as well as chapters in numerous well-known dermatology textbooks. He has lectured nationally and internationally on topics involving lupus, neutrophilic disorders, psoriasis, atopic dermatitis, systemic therapies for dermatologic diseases, drug reactions, advanced dermatologic disorders, and acne. He serves on the editorial review team for JAMA Dermatology, and the Journal of the American Academy of Dermatology, and served as President of the American Acne and Rosacea Society from 2019 to 2021. Mark received his undergraduate degree from Baylor University and his medical degree from Texas A&M College of Medicine.